News - Zdravlje | A Frontier Biopharma Company


Strengthening-Oncology-Treatment-Access-in-the-Western-Balkans.png
02/04/2025

Weโ€™re excited to announce that ๐—™๐—ฟ๐—ผ๐—ป๐˜๐—ถ๐—ฒ๐—ป๐˜ ๐Ÿฐ๐Ÿฌ๐Ÿฌ๐—บ๐—ด (๐—œ๐—ก๐—ก: ๐—ฃ๐—ฎ๐˜‡๐—ผ๐—ฝ๐—ฎ๐—ป๐—ถ๐—ฏ) is now available in Bosnia and Herzegovina, following its launch at the end of March. This marks one of the first generic launches of Pazopanib in the Western Balkans - a step forward in expanding access to oncology treatments in the region. Pazopanib is a potent and selective multi-targeted receptor tyrosine kinase inhibitor approved for the treatment of renal cell carcinoma and soft tissue sarcoma.

Copy-of-Untitled-Design-1.png
18/02/2025

In our second Leading the Way interview, Snezana Stojilkovic, Zdravljeโ€™s Quality Director, shares insights from her 30-year journeyโ€”from researcher to leading quality operations. She discusses the challenges of maintaining top-tier standards in a CDMO, the power of cross-team collaboration, and how our commitment to excellence drives success.

Untitled-design-16-1280x665.png
07/10/2024

Zdravlje recently completed a comprehensive six-day inspection by the European Medicines Authority from September 5-10, concluding successfully with zero critical observations. Recognized with the prestigious EU GMP certification since 2009, our facility continues to uphold full compliance and excellence in quality, innovation, and trust.

Leading-the-Way-1280x855.png
05/09/2024

As part of our new series, Leading The Way, we are proud to bring you exclusive insights from the leaders who are shaping the future of Zdravlje. In each interview, weโ€™ll dive into their unique perspectives, key experiences, and the strategies they employ to drive our company forward. Through these conversations, we aim to highlight the vision, innovation, and leadership that have defined Zdravlje for decades. In this first interview, we sit down with Dusan Cvetanovic, Senior Site Director, to explore his journey and his thoughts on the future of our industry.

Untitled-design-16-1280x763.png
28/08/2024

We are proud to announce that Zdravlje has been ๐—ฐ๐—ฒ๐—ฟ๐˜๐—ถ๐—ณ๐—ถ๐—ฒ๐—ฑ ๐—ฏ๐˜† ๐—˜๐—ฐ๐—ผ๐—ฉ๐—ฎ๐—ฑ๐—ถ๐˜€, an independent ๐—ด๐—น๐—ผ๐—ฏ๐—ฎ๐—น ๐—ฝ๐—ฟ๐—ผ๐˜ƒ๐—ถ๐—ฑ๐—ฒ๐—ฟ ๐—ผ๐—ณ ๐—ฏ๐˜‚๐˜€๐—ถ๐—ป๐—ฒ๐˜€๐˜€ ๐˜€๐˜‚๐˜€๐˜๐—ฎ๐—ถ๐—ป๐—ฎ๐—ฏ๐—ถ๐—น๐—ถ๐˜๐˜† ๐—ฟ๐—ฎ๐˜๐—ถ๐—ป๐—ด๐˜€, placing us in the ๐˜๐—ผ๐—ฝ ๐Ÿฏ๐Ÿฑ% ๐—ผ๐—ณ ๐—ฐ๐—ผ๐—บ๐—ฝ๐—ฎ๐—ป๐—ถ๐—ฒ๐˜€ assessed globally for sustainability! This recognition is especially significant as it follows our first audit in the ESG field. EcoVadis, a globally respected sustainability ratings provider, evaluates companies based on 21 sustainability criteria, including environmental impact, labor and human rights, ethics, and sustainable procurement.

BIO4-campus.jpg
28/12/2023

We are excited to announce Serbia's commencement of constructing the BIO4 campus in Belgrade! This campus is set to become a central hub for innovation, research and collaboration, uniting brilliant minds with cutting-edge technologies. As Zdravlje, we are honoured to play a role in this ground-breaking project, poised to redefine the biotechnology landscape in Europe. Our commitment is to pioneer the development of novel biologics for the prevention and treatment of life-threatening diseases.

Zdravlje-PKS-1280x960.jpg
15/12/2023

The successful and long-term business of Zdravlje was also recognized by the Chamber of Commerce of Serbia (PKS). At the premises of the Regional Chamber of Commerce (RPK) in Leskovac, during the ceremonial session of the Parliament of Businessmen, Zdravlje was presented with the JUBILEE AWARD OF THE CHAMBER OF COMMERCE OF SERBIA for 70 years of successful business.

zdravlje-leskovac-70-years-celebrate-2.jpg
25/11/2023

Zdravlje Leskovac ceremoniously marked a significant milestone - seven decades of dedication to innovation, trust, and quality. The celebration, held on Friday, November 24, brought together more than 350 guests, including our business partners, collaborators, and representatives of institutions who, along with our employees, reminisced about the extensive history of Zdravlje.


How we can help?

Reach out to us and letโ€™s discuss how we can support your pharmaceutical manufacturing needs.


CONTACT US


Zdravlje Company Data | Terms Of Use | Privacy policy | Personal Data Processing

ยฉ 2025 Zdravlje AD Leskovac. All rights reserved.